Clinical trial

A Study of LP-168 in Healthy Volunteers

NCT05432713

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-05-14

PhasePHASE1

Study timeline

Study start (actual)2022-05-14Date precision: day

Registry last updated2023-02-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

NMO Spectrum Disorderunresolved

Interventions

LP-168 tabletDRUG

LP-168 Placebo tabletDRUG

Sponsors & collaborators

Guangzhou Lupeng Pharmaceutical Company LTD.lead sponsor

Mapped research locations

HangzhouZhejiang, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05432713 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.